Boston Scientific Corp. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 01/29/2026 | 139.69 M | $13.32 B | 1.04% | 9.44% |
| BLACKROCK, INC. | 02/12/2026 | 135.99 M | $12.97 B | -6.33% | 9.19% |
| FMR LLC | 02/17/2026 | 97.39 M | $9.29 B | -2.10% | 6.57% |
| STATE STREET CORP | 02/13/2026 | 65.85 M | $6.28 B | 1.42% | 4.45% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 32.38 M | $3.07 B | -0.94% | 2.19% |
| PRIMECAP MANAGEMENT CO/CA/ | 02/11/2026 | 31.10 M | $2.97 B | -6.06% | 2.10% |
| CAPITAL WORLD INVESTORS | 02/11/2026 | 27.15 M | $2.59 B | 1.89% | 1.83% |
| JPMORGAN CHASE & CO | 02/11/2026 | 25.37 M | $2.42 B | -10.44% | 1.71% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 25.12 M | $2.39 B | -25.85% | 1.70% |
| NORGES BANK | 02/10/2026 | 23.07 M | $2.20 B | 100.00% | 1.56% |
| MORGAN STANLEY | 02/13/2026 | 22.96 M | $2.19 B | 10.84% | 1.55% |
| BOLLARD GROUP LLC | 02/13/2026 | 19.00 M | $1.81 B | -3.72% | 1.28% |
| DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | 02/17/2026 | 18.54 M | $1.77 B | 32.13% | 1.25% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 16.58 M | $1.58 B | 10.49% | 1.12% |
| UBS GROUP AG | 01/29/2026 | 14.87 M | $1.42 B | 40.74% | 1.00% |
| NORTHERN TRUST CORP | 02/17/2026 | 13.94 M | $1.33 B | -3.24% | 0.94% |
| INVESCO LTD. | 02/19/2026 | 13.32 M | $1.27 B | -21.49% | 0.90% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 12.59 M | $1.20 B | 5.16% | 0.85% |
| AMUNDI | 02/17/2026 | 12.42 M | $1.18 B | 3.62% | 0.84% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 11.26 M | $1.03 B | 32.14% | 0.76% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 11.25 M | $1.07 B | 26.25% | 0.76% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 11.22 M | $1.07 B | 1.74% | 0.76% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/13/2026 | 11.04 M | $1.05 B | 31.89% | 0.74% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/13/2026 | 10.94 M | $1.04 B | -0.38% | 0.74% |
| LEGAL & GENERAL GROUP PLC | 02/09/2026 | 10.88 M | $1.04 B | 4.01% | 0.73% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 9.71 M | $925.76 M | -33.74% | 0.65% |
| NUVEEN, LLC | 02/12/2026 | 9.37 M | $893.65 M | -2.84% | 0.63% |
| FISHER ASSET MANAGEMENT, LLC | 02/09/2026 | 9.14 M | $871.33 M | 8.00% | 0.62% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 01/22/2026 | 9.09 M | $866.31 M | -12.36% | 0.61% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 8.95 M | $853.05 M | 1.18% | 0.60% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 02/13/2026 | 8.35 M | $796.14 M | 6.90% | 0.56% |
| PARNASSUS INVESTMENTS, LLC | 02/12/2026 | 7.90 M | $753.19 M | 14.74% | 0.53% |
| EDGEWOOD MANAGEMENT LLC | 02/12/2026 | 7.80 M | $744.04 M | -16.10% | 0.53% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/13/2026 | 7.72 M | $736.43 M | 74.33% | 0.52% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 7.46 M | $711.05 M | -10.98% | 0.50% |
| FARALLON CAPITAL MANAGEMENT LLC | 02/17/2026 | 7.44 M | $709.36 M | 56.74% | 0.50% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 02/11/2026 | 7.08 M | $675.47 M | 6.79% | 0.48% |
| CANADA PENSION PLAN INVESTMENT BOARD | 02/17/2026 | 6.86 M | $654.27 M | 30.44% | 0.46% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 6.75 M | $643.44 M | -14.99% | 0.46% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 6.43 M | $613.19 M | 17.11% | 0.43% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 6.30 M | $600.56 M | 17.95% | 0.43% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 5.74 M | $546.89 M | 32.93% | 0.39% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 5.68 M | $541.21 M | -17.45% | 0.38% |
| ROYAL BANK OF CANADA | 02/17/2026 | 5.55 M | $529.34 M | -28.02% | 0.38% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 5.51 M | $524.99 M | -16.48% | 0.37% |
| JENNISON ASSOCIATES LLC | 01/30/2026 | 5.47 M | $521.40 M | 10.72% | 0.37% |
| NINETY ONE UK LTD | 01/27/2026 | 5.44 M | $519.14 M | 1.51% | 0.37% |
| EGERTON CAPITAL (UK) LLP | 02/11/2026 | 5.39 M | $513.47 M | 1.37% | 0.36% |
| CITADEL ADVISORS LLC | 02/17/2026 | 4.78 M | $455.36 M | -46.38% | 0.32% |
| FIL LTD | 02/17/2026 | 4.76 M | $453.68 M | 2.14% | 0.32% |
Boston Scientific Corp. institutional Ownership - FAQ's
During the previous two years, 2393 institutional investors and hedge funds held shares of Boston Scientific Corp.. The most heavily invested institutionals were:
PRIMECAP MANAGEMENT CO/CA/: 32.53 M
UBS Group AG: 14.82 M
Nuveen, LLC: 11.73 M
Legal & General Group Plc: 10.6 M
Assenagon Asset Management S.A.: 10.06 M
Bank of New York Mellon Corp: 9.54 M
92.06% of Boston Scientific Corp. stock is owned by institutional investors.
Institutional investors have bought a total of 1.84 B shares in the last 24 months. This purchase volume represents approximately $132.02 B in transactions.